Nuo Therapeutics, Inc. (AURX)
OTC: AURX · CIK 0001091596 · United States
Every official Nuo Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open AURX filings
Nuo Therapeutics, Inc. documents
- Nuo Therapeutics, Inc. 10-K 2026AURX 10-K 2026: annual report for fiscal 2026
- Nuo Therapeutics, Inc. 10-K 2025AURX 10-K 2025: annual report for fiscal 2025
- Nuo Therapeutics, Inc. 10-K 2024AURX 10-K 2024: annual report for fiscal 2024
- Nuo Therapeutics, Inc. 10-K 2023AURX 10-K 2023: annual report for fiscal 2023
- Nuo Therapeutics, Inc. 10-K 2022AURX 10-K 2022: annual report for fiscal 2022
- Nuo Therapeutics, Inc. 10-Q 2026AURX 10-Q 2026: quarterly report for fiscal 2026
- Nuo Therapeutics, Inc. 10-Q 2025AURX 10-Q 2025: quarterly report for fiscal 2025
- Nuo Therapeutics, Inc. 10-Q 2024AURX 10-Q 2024: quarterly report for fiscal 2024
- Nuo Therapeutics, Inc. 10-Q 2023AURX 10-Q 2023: quarterly report for fiscal 2023
- Nuo Therapeutics, Inc. 10-Q 2022AURX 10-Q 2022: quarterly report for fiscal 2022
- Nuo Therapeutics, Inc. 8-K 2026AURX 8-K 2026: current report for fiscal 2026
- Nuo Therapeutics, Inc. 8-K 2025AURX 8-K 2025: current report for fiscal 2025
- Nuo Therapeutics, Inc. 8-K 2024AURX 8-K 2024: current report for fiscal 2024
- Nuo Therapeutics, Inc. 8-K 2023AURX 8-K 2023: current report for fiscal 2023
- Nuo Therapeutics, Inc. 8-K 2022AURX 8-K 2022: current report for fiscal 2022
- Nuo Therapeutics, Inc. DEF 14A 2026AURX DEF 14A 2026: proxy statement for fiscal 2026
- Nuo Therapeutics, Inc. DEF 14A 2025AURX DEF 14A 2025: proxy statement for fiscal 2025
- Nuo Therapeutics, Inc. DEF 14A 2024AURX DEF 14A 2024: proxy statement for fiscal 2024
- Nuo Therapeutics, Inc. DEF 14A 2023AURX DEF 14A 2023: proxy statement for fiscal 2023
- Nuo Therapeutics, Inc. DEF 14A 2022AURX DEF 14A 2022: proxy statement for fiscal 2022
- Nuo Therapeutics, Inc. Form 4 2026AURX Form 4 2026: insider trading filing for fiscal 2026
- Nuo Therapeutics, Inc. Form 4 2025AURX Form 4 2025: insider trading filing for fiscal 2025
- Nuo Therapeutics, Inc. Form 4 2024AURX Form 4 2024: insider trading filing for fiscal 2024
- Nuo Therapeutics, Inc. Form 4 2023AURX Form 4 2023: insider trading filing for fiscal 2023
- Nuo Therapeutics, Inc. Form 4 2022AURX Form 4 2022: insider trading filing for fiscal 2022
- Nuo Therapeutics, Inc. S-1 2026AURX S-1 2026: registration statement for fiscal 2026
- Nuo Therapeutics, Inc. S-1 2025AURX S-1 2025: registration statement for fiscal 2025
- Nuo Therapeutics, Inc. S-1 2024AURX S-1 2024: registration statement for fiscal 2024
- Nuo Therapeutics, Inc. S-1 2023AURX S-1 2023: registration statement for fiscal 2023
- Nuo Therapeutics, Inc. S-1 2022AURX S-1 2022: registration statement for fiscal 2022
- Nuo Therapeutics, Inc. 13F 2026AURX 13F 2026: institutional holdings for fiscal 2026
- Nuo Therapeutics, Inc. 13F 2025AURX 13F 2025: institutional holdings for fiscal 2025
- Nuo Therapeutics, Inc. 13F 2024AURX 13F 2024: institutional holdings for fiscal 2024
- Nuo Therapeutics, Inc. 13F 2023AURX 13F 2023: institutional holdings for fiscal 2023
- Nuo Therapeutics, Inc. 13F 2022AURX 13F 2022: institutional holdings for fiscal 2022
More companies